PDIDX Performance — PGIM Target Date 2045 Fund, Class R1
Data updated: 2026-10-13
PDIDX returned +10.54% year to date and +19.55% over one year to Jul 2026. Annualised returns are +14.23% over 3 years and +8.12% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $149, against $146 for the category, and to $120 over one year, against $116. Volatility over the past three years was 10.58% a year. In the 12 months to Jul 2026 the fund lost a net $438K, and assets reached $35.39M.
PDIDX Growth of $100
What $100 invested in PGIM Target Date 2045 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | PDIDX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $120 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $149 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $148 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $200 | $186 |
PDIDX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.54% |
| 1 year | +19.55% |
| 3 years (annualised) | +14.23% |
| 5 years (annualised) | +8.12% |
PDIDX Annual Returns
Calendar-year total returns of PGIM Target Date 2045 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +10.54% |
| 2025 | +16.79% |
| 2024 | +11.99% |
| 2023 | +16.38% |
| 2022 | −15.55% |
| 2021 | +18.20% |
| 2020 | +10.80% |
| 2019 (Aug–Dec) | +7.33% |
PDIDX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.0% | +2.0% | −5.5% | +8.0% | +3.2% | +0.4% | −0.4% | — | — | — | — | — |
| 2025 | +2.8% | −0.2% | −2.8% | 0.0% | +4.2% | +3.6% | +0.3% | +2.9% | +2.5% | +1.4% | +0.7% | +0.5% |
| 2024 | −0.2% | +3.2% | +2.8% | −3.4% | +4.0% | +1.0% | +2.1% | +2.2% | +2.0% | −2.4% | +3.3% | −2.8% |
| 2023 | +6.5% | −2.9% | +1.8% | +0.8% | −1.6% | +5.0% | +3.0% | −2.3% | −3.9% | −2.8% | +7.6% | +5.0% |
| 2022 | −3.8% | −1.5% | +1.4% | −6.4% | +0.5% | −8.2% | +6.9% | −3.8% | −9.1% | +5.8% | +7.1% | −4.0% |
| 2021 | +0.1% | +2.7% | +3.1% | +3.9% | +1.5% | +0.6% | +1.0% | +1.8% | −3.6% | +4.2% | −2.3% | +4.1% |
| 2020 | −1.4% | −7.2% | −13.9% | +9.6% | +4.6% | +2.6% | +4.1% | +4.5% | −2.9% | −1.7% | +10.2% | +4.3% |
| 2019 | — | — | — | — | — | — | — | −1.7% | +1.9% | +2.2% | +2.1% | +2.7% |
PDIDX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 10.58%
- 3-year Sharpe ratio: 0.92 (vs 4.5% risk-free rate)
- Best month: +7.99% (Apr 2026)
- Worst month: −5.50% (Mar 2026)
PDIDX Fund Flows
Monthly money in and out of PGIM Target Date 2045 Fund, from SEC Form N-PORT.
- 12-month net flow: −$438K
- 12-month gross sales (incl. reinvestments): $7.6M
- Sales ÷ redemptions: 0.95×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $426K | $87K | $338K |
| Jun 2026 | $184K | $507K | −$323K |
| May 2026 | $178K | $2.2M | −$2.0M |
| Apr 2026 | $181K | $446K | −$265K |
| Mar 2026 | $506K | $2.0M | −$1.5M |
| Feb 2026 | $215K | $525K | −$309K |
| Jan 2026 | $509K | $1.4M | −$914K |
| Dec 2025 | $4.0M | $49K | $3.9M |
| Nov 2025 | $209K | $199K | $10K |
| Oct 2025 | $477K | $202K | $274K |
| Sep 2025 | $178K | $209K | −$31K |
| Aug 2025 | $533K | $108K | $426K |
PDIDX Assets Under Management
Net assets of PGIM Target Date 2045 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $35.39M |
| 2026-04-30 | $36.28M |
| 2026-01-30 | $36.92M |
| 2025-10-31 | $33.83M |
| 2025-07-31 | $30.95M |
| 2025-04-30 | $28.42M |
| 2025-01-31 | $28.30M |
| 2024-10-31 | $27.51M |
| 2024-07-31 | $26.49M |
| 2024-04-30 | $23.76M |
| 2024-01-31 | $22.06M |
| 2023-10-31 | $30.26M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.